Loading patent…
AssigneeThe Research Foundation for The State University of New York
InventorSrinivas Pentyala
Estimating the term…
The present invention is based, in part, on our discovery of compositions and methods that can be used to treat a patient who has a compromised bone (due, for example, to a disease such as osteoporosis or an injury such as a bone fracture). The compositions can also be administered prophylactically. For example, they can be administered to help maintain bone health as a patient ages. More specifically, the compositions include polypeptides that constitute (or that include) a fragment of a calcitonin receptor (CR) and polypeptides that constitute (or include) biologically active variants of those fragments. Sequence-specific formulas are provided herein, and polypeptides conforming to those formulas, as well as nucleic acids encoding them, expression vectors, host cells, pharmaceutical formulations, and methods of their preparation and use are within the scope of the present invention.
A substantially pure polypeptide comprising a fragment of a calcitonin receptor, wherein the polypeptide comprises an amino acid sequence conforming to Trp-Val-Gln-Phe-Lys-Ile-Gln-Trp-Asn-Gln-Arg-Trp (SEQ ID NO:5), and wherein the polypeptide is 12-18 amino acids in length and is amidated at the C-terminus.
A substantially pure polypeptide comprising a fragment of a calcitonin receptor, wherein the polypeptide comprises an amino acid sequence conforming to Trp-Ala-Gln-Phe-Lys-Ile-Gln-Trp-Ser-His-Arg-Trp (SEQ ID NO:7), and wherein the polypeptide is 12-18 amino acids in length and is amidated at the C-terminus.
A substantially pure polypeptide comprising a fragment of a calcitonin receptor, wherein the polypeptide comprises an amino acid sequence conforming to:
A substantially pure polypeptide comprising a fragment of a calcitonin receptor, wherein the polypeptide comprises an amino acid sequence conforming to:
A pharmaceutical composition comprising one or more substantially pure polypeptides comprising a fragment of a calcitonin receptor, wherein the one or more polypeptides comprises one or more amino acid sequences conforming to:
A kit comprising:
A substantially pure polypeptide comprising a fragment of a calcitonin receptor, wherein the polypeptide consists of an amino acid sequence conforming to:
A pharmaceutical composition comprising one or more substantially pure polypeptides comprising a fragment of a calcitonin receptor, wherein the one or more polypeptides consist of one or more amino acid sequences conforming to:
A kit comprising:
Dependencies are inferred from the claim text.